1 year return (CAGR)
-84.24%
Transcode Therapeutics Inc Exchange (NASDAQ, USD)
RNAZ
1.77
+0.01 (+0.57%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-87.81%
5 year return (CAGR)
-88.08%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.87M
Price/Sales
-
Ent value
6.14M
Price/Book
0.01
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-6693.61%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-65.47%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.87 |
| Daily high | 1.91 |
| Daily low | 1.71 |
| Daily Volume | 57K |
| All-time high | 170280.00 |
| 1y analyst estimate | 10.00 |
| Beta | 1.24 |
| EPS (TTM) | -45.65 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| RNAZ | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.58% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 14 May 2025 | 9 Mar 2009 |
| Avg drop from high | -89.98% | -10.68% |
| Avg time to new high | 327 days | 12 days |
| Max time to new high | 1305 days | 1805 days |
News
